The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

spinalrestoration.com

Executives

1

Board of Directors

2

Spinal Restoration Board of Directors

2 Board of directors

Spinal Restoration has 2 board of directors, including Gary Stevenson.

Name

Firm

Work History

Other Seats

Gary Stevenson

Gary co-founded MB Venture Partners in 2001 after six years in healthcare investment banking and research. He also spent seven years in a variety of general management roles with Abbott Laboratories, one of the largest and most diversified healthcare companies in the world. He is a certified public accountant and a chartered financial analyst. Gary is a board member or observer for several MBVP portfolio companies and also serves on the board of Life Science Tennessee and ZeroTo510.

Spinal Restoration

Kevin Lalande

Kevin Lalande is managing director of Santé Ventures, a life science venture capital firm he co-founded in 2006 that currently manages $525 million in capital in three funds. Santé Ventures helps create and finance innovative new healthcare and life science companies, including: LDR Medical (Zimmer Biomet), Explorys (IBM Corp), AbVitro (Celegene Corp), Molecular Templates (Nasdaq:MTEM), Millipede Medical (Boston Scientific), TVA Medical (Becton Dickenson), and Claret Medical (Boston Scientific). Kevin is also the founder and chief investment officer of Santé Capital, a quantitative hedge fund that began trading capital in 2015 based on a set of machine learning algorithms he developed. Prior to his current roles, Kevin spent seven years as a venture capitalist with Austin Ventures and before that was a management consultant with McKinsey & Company. Kevin holds a bachelor’s degree with honors in Electrical & Computer Engineering, an MBA with highest distinction from the Harvard Business School, where he was both a Baker Scholar and a Siebel Scholar, and a graduate certificate in Artificial Intelligence from Stanford University. Kevin Lalande is managing director of Santé Ventures, a life science venture capital firm he co-founded in 2006 that currently manages $525 million in capital in three funds. Santé Ventures helps create and finance innovative new healthcare and life science companies, including: LDR Medical (Zimmer Biomet), Explorys (IBM Corp), AbVitro (Celegene Corp), Molecular Templates (Nasdaq:MTEM), Millipede Medical (Boston Scientific), TVA Medical (Becton Dickenson), and Claret Medical (Boston Scientific).

Spinal Restoration

Name

Gary Stevenson

Kevin Lalande

Firm

Work History

Gary co-founded MB Venture Partners in 2001 after six years in healthcare investment banking and research. He also spent seven years in a variety of general management roles with Abbott Laboratories, one of the largest and most diversified healthcare companies in the world. He is a certified public accountant and a chartered financial analyst. Gary is a board member or observer for several MBVP portfolio companies and also serves on the board of Life Science Tennessee and ZeroTo510.

Kevin Lalande is managing director of Santé Ventures, a life science venture capital firm he co-founded in 2006 that currently manages $525 million in capital in three funds. Santé Ventures helps create and finance innovative new healthcare and life science companies, including: LDR Medical (Zimmer Biomet), Explorys (IBM Corp), AbVitro (Celegene Corp), Molecular Templates (Nasdaq:MTEM), Millipede Medical (Boston Scientific), TVA Medical (Becton Dickenson), and Claret Medical (Boston Scientific). Kevin is also the founder and chief investment officer of Santé Capital, a quantitative hedge fund that began trading capital in 2015 based on a set of machine learning algorithms he developed. Prior to his current roles, Kevin spent seven years as a venture capitalist with Austin Ventures and before that was a management consultant with McKinsey & Company. Kevin holds a bachelor’s degree with honors in Electrical & Computer Engineering, an MBA with highest distinction from the Harvard Business School, where he was both a Baker Scholar and a Siebel Scholar, and a graduate certificate in Artificial Intelligence from Stanford University. Kevin Lalande is managing director of Santé Ventures, a life science venture capital firm he co-founded in 2006 that currently manages $525 million in capital in three funds. Santé Ventures helps create and finance innovative new healthcare and life science companies, including: LDR Medical (Zimmer Biomet), Explorys (IBM Corp), AbVitro (Celegene Corp), Molecular Templates (Nasdaq:MTEM), Millipede Medical (Boston Scientific), TVA Medical (Becton Dickenson), and Claret Medical (Boston Scientific).

Other Seats

Spinal Restoration

Spinal Restoration

Spinal Restoration Management Team

1 Team Member

Spinal Restoration has 1 executive. Spinal Restoration's founder is Steven I. Whitlock.

Name

Work History

Title

Status

Steven I. Whitlock

Ortho Kinematics, PTV Sciences, LDR Spine, and Path4 Ventures

Founder

Current

Name

Steven I. Whitlock

Work History

Ortho Kinematics, PTV Sciences, LDR Spine, and Path4 Ventures

Title

Founder

Status

Current

You May Also Like

D
Disc Dynamics

Disc Dynamics has developed the DASCORTM Disc Arthroplasty System, an innovative, minimally invasive nucleus replacement treatment for patients suffering from chronic low back pain caused by Degenerative Disc Disease (DDD).

MicroTransponder Logo
MicroTransponder

MicroTransponder develops a wireless neurostimulation system for the treatment of chronic pain and several other neurological indications. The minimally invasive device will provide relief from chronic pain without requiring an implanted battery or wires. The Company is finishing R&D on the device and accumulating data toward FDA clearance. MicroTransponder is also adapting the company's system for Vagus Nerve Stimulation to create a pipeline of treatments for other neurological indications, including stroke rehabilitation, tinnitus, and autism.

A
Axial Biotech

Axial Biotech, founded in 2002 by a group of spine surgeons and geneticists, is focused on the use of genetics and the development of minimally invasive fusionless devices to advance the diagnosis and treatment of diseases and deformities of the human spine. Axial is a company to pursue DNA-based pre-symptomatic and prognostic tests for common spinal conditions which will augment current clinical and surgical practices. In its initial genetic product development initiative, Axial has made progress towards the discovery of a location in the human genome that is associated with adolescent idiopathic scoliosis. In addition, Axial's founders have developed five motion preserving, fusionless surgical devices (including such device currently being implanted in humans) that have the promise of expanding the current treatable scoliosis patient population by a factor of ten. Axial intends to use its genetic intellectual property in the development of bio-mechanical devices, and to apply its gene discovery/product development methodology to other spinal diseases. Axial (www.axialbiotech.com) is located in Salt Lake City, Utah.

B
Biospiral

BioSpiral's state-of-art system aims to provide prostate cancer treatment as a minimally invasive procedure, which uses cooling & heating technologies to destroy prostate cancer.nBioSpiral was established in Sep 2006 and is operating as part of NGT Incubator. nBioSpiral prostate thermodynamics therapy is an effective, minimally invasive treatment for prostate cancer that does not involve the difficulty and complications associated with surgery, nor the harmful properties of radiation or cryotherapy .The system revolutionizes prostate cancer treatment by introducing a "one shot" treatment method under local anesthesia at the physician's clinic. BioSpiral treatment is for patients with localized prostate cancer, who look for an effective minimal invasive therapy for prostate cancer. Additionally, this treatment can also be used by patients who have local recurrence after other treatments ("salvage" treatment). Key advantages:nCost effective: short treatment, no need for O.R or hospitalizationnHighly efficient: tissue ablationnPatients: high quality of life; minimal side effects, minimal invasive, short treatment & recovery.

S
Simpirica Spine

Simpirica is developing a dynamic stabilization system designed to stabilize the spine in flexion and help patients return to more healthy, active lifestyles. The company's lead product, the LimiFlex Spinal Stabilization System, is typically used in conjunction with a surgical decompression for the treatment of lumbar spinal stenosis with or without degenerative spondylolisthesis.

Spine Wave Logo
Spine Wave

Spine Wave is developing a procedure for treating back pain and other spinal conditions by restoring the function of the spinal disc. The procedure uses an injectable protein-based formulation for the repair of spinal discs damaged either by injury or aging.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.